Webinar | Immunotherapy, SBRT, & The Tumor Immune Ecosystem

The Expanding Use of SBRT in Radiation Therapy Education Course
November 15-16, 2018
The Princess Margaret Cancer Centre, Toronto, ON, Canada
Keynote Address Webinar
Immunotherapy, SBRT, & The Tumor Immune Ecosystem
Dr. Jonathan Schoenfeld, Dana-Farber Cancer Centre, Harvard Medical School, Boston, MA, USA
Description:
Immunotherapy has revolutionized oncology, yet the majority of patients either don’t respond or progress on this treatment. Pre-clinical data suggest radiation may help address some of the limitations of immune therapy. Clinical experience suggests several important roles SBRT may play in this partnership in order to maximize the effectiveness of combined therapy.
Speaker Bio:
Dr. Jonathan Schoenfeld is a radiation oncologist at the Brigham and Women / Dana-Farber Cancer Center, and Harvard Medical School, and serves as the Radiation Oncology Director of the Melanoma Disease Center at the Dana-Farber Cancer Institute. He received his medical degree from Harvard Medical School, and a research fellowship at the University of Cambridge. He completed his residency in radiation oncology in the Harvard Radiation Program, and a Master of Public Health in Clinical Effectiveness from the Harvard T.H. Chan School of Public Health. Dr. Schoenfeld currently serves on the NCI Radiation and Immune Modulation Working Group, and the Developmental Therapeutics Subcommittee for NRG oncology. He leads multicenter and international trials testing the combination of radiation and immune therapy and translational studies evaluating the effect of highly targeted radiation and novel therapies on the immune microenvironment.